Mosaic Therapeutics
Cambridge
About Mosaic Therapeutics
Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients. The company utilizes a proprietary platform to identify synergistic drug combinations based on biomarker-defined patient populations, aiming to improve the efficacy and durability of responses. Mosaic Therapeutics' research focuses on identifying specific biomarkers that can be targeted with tailored drug combinations, enhancing the effectiveness of treatments for individual patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.0M
- Last round: Corporate Round (Apr 2025)
- Website: mosaic-tx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mosaic-therapeutics-5912 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.